04:41 PM EDT, 07/02/2025 (MT Newswires) -- Nektar Therapeutics ( NKTR ) said Wednesday it has closed an underwritten public offering of $115 million of its shares, including the full exercise of an over-allotment option.
Net proceeds will be used for general corporate purposes, the company said.